These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

949 related items for PubMed ID: 16000355

  • 1. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB.
    N Engl J Med; 2005 Jul 07; 353(1):46-57. PubMed ID: 16000355
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, Curtiss LK, Witztum JL, Strauss BH.
    Circulation; 2004 Jun 29; 109(25):3164-70. PubMed ID: 15184281
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
    Ducas J, Silversides C, Dembinski TC, Chan MC, Tate R, Dick A, Nixon P, Ren S, Shen GX.
    Clin Invest Med; 2002 Jun 29; 25(3):74-82. PubMed ID: 12137255
    [Abstract] [Full Text] [Related]

  • 5. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J.
    Can J Cardiol; 1997 Mar 29; 13(3):253-60. PubMed ID: 9117913
    [Abstract] [Full Text] [Related]

  • 6. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
    Merki E, Graham MJ, Mullick AE, Miller ER, Crooke RM, Pitas RE, Witztum JL, Tsimikas S.
    Circulation; 2008 Aug 12; 118(7):743-53. PubMed ID: 18663084
    [Abstract] [Full Text] [Related]

  • 7. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L, Deepa R, Mohan A, Mohan V.
    Indian Heart J; 2000 Aug 12; 52(4):400-6. PubMed ID: 11084779
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R, Mahajan M, Singh B, Bal BS, Kant R.
    J Indian Med Assoc; 2006 Sep 12; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [Abstract] [Full Text] [Related]

  • 9. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S, Kiechl S, Willeit J, Mayr M, Miller ER, Kronenberg F, Xu Q, Bergmark C, Weger S, Oberhollenzer F, Witztum JL.
    J Am Coll Cardiol; 2006 Jun 06; 47(11):2219-28. PubMed ID: 16750687
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G, Cuomo S, Capozzi G, Foglia MC, Barra S, Madrid A, Stornaiuolo V, Trevisan M.
    Nutr Metab Cardiovasc Dis; 2008 Sep 06; 18(7):492-6. PubMed ID: 17962002
    [Abstract] [Full Text] [Related]

  • 11. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
    Carantoni M, Zuliani G, Bader G, Palmieri E, Volpato S, Passaro A, Imbastaro T, Mezzetti A, Fellin R.
    Nutr Metab Cardiovasc Dis; 1999 Oct 06; 9(5):228-33. PubMed ID: 10656169
    [Abstract] [Full Text] [Related]

  • 12. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S, MIRACL Study Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2186-96. PubMed ID: 19497447
    [Abstract] [Full Text] [Related]

  • 13. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
    Bossola M, Tazza L, Luciani G, Tortorelli A, Tsimikas S.
    J Nephrol; 2011 Jun 09; 24(5):581-8. PubMed ID: 21404224
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
    Ben Hamda K, Masmoudi AS, Mandhouj O, Hammami S, Attia N, Smaoui M, Zidi MA, Nabli N, Chaaba R, Mahjoub S, Ben Farhat M, Hammami M.
    Arch Inst Pasteur Tunis; 2002 Jun 09; 79(1-4):27-33. PubMed ID: 15072242
    [Abstract] [Full Text] [Related]

  • 16. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
    Wang JJ, Han AZ, Meng Y, Gong JB, Zhang CN, Li K, Liu YX.
    Clin Biochem; 2010 Apr 09; 43(6):571-5. PubMed ID: 20060390
    [Abstract] [Full Text] [Related]

  • 17. LDL molecular size as risk factor in coronary artery disease.
    Kozma L, Fodor J, Chockalingam A, Sussex B.
    Acta Med Hung; 2010 Apr 09; 49(1-2):65-77. PubMed ID: 1296188
    [Abstract] [Full Text] [Related]

  • 18. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A, Rothenbacher D, Khuseyinova N, Hoffmeister A, Maerz W, Nauck M, Scharnagl H, Koenig W, Brenner H.
    Eur J Cardiovasc Prev Rehabil; 2003 Oct 09; 10(5):362-70. PubMed ID: 14663298
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV, Kaplun VV, Dvoryantsev SN, Orekhov AN.
    Biochem Biophys Res Commun; 1995 Sep 14; 214(2):608-13. PubMed ID: 7677772
    [Abstract] [Full Text] [Related]

  • 20. Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.
    Sharobeem KM, Patel JV, Ritch AE, Lip GY, Gill PS, Hughes EA.
    Int J Clin Pract; 2007 Nov 14; 61(11):1824-8. PubMed ID: 17935546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.